2010
DOI: 10.1016/j.yrtph.2010.03.010
|View full text |Cite
|
Sign up to set email alerts
|

In silico approaches to predicting cancer potency for risk assessment of genotoxic impurities in drug substances

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(8 citation statements)
references
References 35 publications
0
8
0
Order By: Relevance
“…is the alkyl halides chemical class, which often occurs in data sets with industrial chemicals but to a lesser extent in drug‐like molecules (Naven et al ., ). The QSAR models that are built using in‐house proprietary data might be advantageous at least for the user, as these are customized models based upon the chemical structures frequently seen during development, and algorithms and software specialized for their own organizational use (Boyer, ; Bercu et al ., ; Naven et al ., ). The disadvantage of such systems is that, because of their proprietary nature, there is little interpretability or verification available for regulatory authorities upon submission of computational toxicology data to support the safety of a substance under review.…”
Section: In Silico (Q)sarmentioning
confidence: 98%
“…is the alkyl halides chemical class, which often occurs in data sets with industrial chemicals but to a lesser extent in drug‐like molecules (Naven et al ., ). The QSAR models that are built using in‐house proprietary data might be advantageous at least for the user, as these are customized models based upon the chemical structures frequently seen during development, and algorithms and software specialized for their own organizational use (Boyer, ; Bercu et al ., ; Naven et al ., ). The disadvantage of such systems is that, because of their proprietary nature, there is little interpretability or verification available for regulatory authorities upon submission of computational toxicology data to support the safety of a substance under review.…”
Section: In Silico (Q)sarmentioning
confidence: 98%
“…Furthermore, regulatory criteria have been defined for the use of in silico predictions in drug safety for the genotoxicity evaluation of drug impurities where the presence or absence of specific structural alerts triggers the subsequent management of potential risk posed by the presence of this impurity [39,40]. In this context, new models have been recently proposed to estimate genotoxic or carcinogenic potency in order to estimate safety [40,41] Very good results have been obtained in the evaluation of genotoxic impurities in the industrial sector when in silico data were coupled with expert evaluation [40] achieving a negative predictive value of 99%.…”
Section: Regulatory Context For In Silico Modelsmentioning
confidence: 99%
“…(1) can be transformed as follows: (2) is a converted value from the genotoxicity of tap water to 4NQO. The VSD 4NQO was estimated as 0.86 ng/kg/d based on previous reports (Ando, 1981;Urano et al, 1995) and according to assumption i) (Bercu et al, 2010). The GA values, corresponding to the 10 -5 level of carcinogenic risk, could then be roughly estimated using Eq.…”
Section: Significance Level Of Ga Valuesmentioning
confidence: 99%